BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 17828604)

  • 1. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.
    Strachan LR; Stevenson TJ; Freshner B; Keefe MD; Miranda Bowles D; Bonkowsky JL
    Hum Mol Genet; 2017 Sep; 26(18):3600-3614. PubMed ID: 28911205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.
    Pujol A; Ferrer I; Camps C; Metzger E; Hindelang C; Callizot N; Ruiz M; Pàmpols T; Giròs M; Mandel JL
    Hum Mol Genet; 2004 Dec; 13(23):2997-3006. PubMed ID: 15489218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of X-linked adrenoleukodystrophy.
    Berger J; Forss-Petter S; Eichler FS
    Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
    Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
    Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
    Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
    PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain endothelial dysfunction in cerebral adrenoleukodystrophy.
    Musolino PL; Gong Y; Snyder JM; Jimenez S; Lok J; Lo EH; Moser AB; Grabowski EF; Frosch MP; Eichler FS
    Brain; 2015 Nov; 138(Pt 11):3206-20. PubMed ID: 26377633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.
    Berger J; Gärtner J
    Biochim Biophys Acta; 2006 Dec; 1763(12):1721-32. PubMed ID: 16949688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
    Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
    J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-α on oligodendrocytes and astrocytes.
    Baarine M; Ragot K; Athias A; Nury T; Kattan Z; Genin EC; Andreoletti P; Ménétrier F; Riedinger JM; Bardou M; Lizard G
    Neurotoxicology; 2012 Mar; 33(2):212-28. PubMed ID: 22057157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy.
    Özgür-Günes Y; Chedik M; Le Stunff C; Fovet CM; Bougnères P
    Hum Gene Ther; 2022 Sep; 33(17-18):936-949. PubMed ID: 35166123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy.
    Weinhofer I; Zierfuss B; Hametner S; Wagner M; Popitsch N; Machacek C; Bartolini B; Zlabinger G; Ohradanova-Repic A; Stockinger H; Köhler W; Höftberger R; Regelsberger G; Forss-Petter S; Lassmann H; Berger J
    Brain; 2018 Aug; 141(8):2329-2342. PubMed ID: 29860501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypomyelination of the murine CNS in the absence of myelin-associated glycoprotein and fyn tyrosine kinase.
    Biffiger K; Bartsch S; Montag D; Aguzzi A; Schachner M; Bartsch U
    J Neurosci; 2000 Oct; 20(19):7430-7. PubMed ID: 11007902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
    Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
    Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.